These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21104588)

  • 41. High plasma phospholipase A2 activity, inflammation markers, and LDL alterations in obesity with or without type 2 diabetes.
    Garces F; López F; Niño C; Fernandez A; Chacin L; Hurt-Camejo E; Camejo G; Apitz-Castro R
    Obesity (Silver Spring); 2010 Oct; 18(10):2023-9. PubMed ID: 20134414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia.
    Wang G; Dai J; Mao J; Zeng X; Yang X; Wang X
    Atherosclerosis; 2005 Apr; 179(2):395-402. PubMed ID: 15777559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential regulation of proinflammatory mediators following LPS- and ATP-induced activation of monocytes from patients with antiphospholipid syndrome.
    Martirosyan A; Petrek M; Navratilova Z; Blbulyan A; Boyajyan A; Manukyan G
    Biomed Res Int; 2015; 2015():292851. PubMed ID: 25785264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased Expression of the Innate Immune Receptor TLR10 in Obesity and Type-2 Diabetes: Association with ROS-Mediated Oxidative Stress.
    Sindhu S; Akhter N; Kochumon S; Thomas R; Wilson A; Shenouda S; Tuomilehto J; Ahmad R
    Cell Physiol Biochem; 2018; 45(2):572-590. PubMed ID: 29428931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects.
    Piarulli F; Sartore G; Sechi A; Basso D; Fogar P; Greco E; Ragazzi E; Lapolla A
    Oxid Med Cell Longev; 2017; 2017():9185272. PubMed ID: 29225725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum resistin levels inversely associated with cardiovascular risk indices in type 2 diabetics from central Mexico.
    Solis-Cano DG; Porchia LM; Gonzalez-Mejia ME; Pérez-Fuentes R; Ruiz-Vivanco G; Nieva-Vazquez A; Torres-Rasgado E
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S1053-S1057. PubMed ID: 28760596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide.
    Szalowska E; Elferink MG; Hoek A; Groothuis GM; Vonk RJ
    J Clin Endocrinol Metab; 2009 Aug; 94(8):3051-7. PubMed ID: 19454585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients.
    Baldeón R L; Weigelt K; de Wit H; Ozcan B; van Oudenaren A; Sempértegui F; Sijbrands E; Grosse L; Freire W; Drexhage HA; Leenen PJ
    PLoS One; 2014; 9(12):e115209. PubMed ID: 25500583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation.
    Baldeón R L; Weigelt K; de Wit H; Ozcan B; van Oudenaren A; Sempértegui F; Sijbrands E; Grosse L; van Zonneveld AJ; Drexhage HA; Leenen PJ
    PLoS One; 2015; 10(6):e0129421. PubMed ID: 26083362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered monocyte calcium-sensing receptor expression in patients with type 2 diabetes mellitus and atherosclerosis.
    Malecki R; Fiodorenko-Dumas Z; Jakobsche-Policht U; Malodobra M; Adamiec R
    J Physiol Pharmacol; 2013 Aug; 64(4):521-7. PubMed ID: 24101400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased spontaneous CCL2 (MCP-1) and CCL5 (RANTES) secretion in vitro in LADA compared to type 1 diabetes and type 2 diabetes: Action LADA 14.
    Ooms M; Strom A; Strassburger K; Menart B; Leslie RD; Schloot NC
    Diabetes Metab Res Rev; 2021 Oct; 37(7):e3431. PubMed ID: 33369072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age-associated decline of monocyte insulin sensitivity in diabetic and healthy individuals.
    Nakamura S; Mori K; Okuma H; Sekine T; Miyazaki A; Tsuchiya K
    Diab Vasc Dis Res; 2021; 18(1):1479164121989281. PubMed ID: 33611932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulated microRNA-155 expression in peripheral blood mononuclear cells of type 2 diabetic patients is not correlated with increased inflammatory cytokine production.
    Mazloom H; Alizadeh S; Pasalar P; Esfahani EN; Meshkani R
    Cytokine; 2015 Dec; 76(2):403-408. PubMed ID: 26188366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poly (ADP-ribose) polymerase-1-inhibiting flavonoids attenuate cytokine release in blood from male patients with chronic obstructive pulmonary disease or type 2 diabetes.
    Weseler AR; Geraets L; Moonen HJ; Manders RJ; van Loon LJ; Pennings HJ; Wouters EF; Bast A; Hageman GJ
    J Nutr; 2009 May; 139(5):952-7. PubMed ID: 19321592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes.
    Sindhu S; Akhter N; Arefanian H; Al-Roub AA; Ali S; Wilson A; Al-Hubail A; Al-Beloushi S; Al-Zanki S; Ahmad R
    J Diabetes Metab Disord; 2017; 16():15. PubMed ID: 28396851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory Response.
    Adda-Rezig H; Carron C; Pais de Barros JP; Choubley H; Charron É; Rérole AL; Laheurte C; Louvat P; Gaiffe É; Simula-Faivre D; Deckert V; Lagrost L; Saas P; Ducloux D; Bamoulid J
    Front Immunol; 2021; 12():658404. PubMed ID: 34163471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression profiling feline peripheral blood monocytes identifies a transcriptional signature associated with type two diabetes mellitus.
    O'Leary CA; Sedhom M; Reeve-Johnson M; Mallyon J; Irvine KM
    Vet Immunol Immunopathol; 2017 Apr; 186():1-8. PubMed ID: 28413044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adiponectin downregulates galectin-3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes.
    Weber M; Sporrer D; Weigert J; Wanninger J; Neumeier M; Wurm S; Stögbauer F; Kopp A; Bala M; Schäffler A; Buechler C
    FEBS Lett; 2009 Nov; 583(22):3718-24. PubMed ID: 19818774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered release of chemokines by phagocytes from fibromyalgia patients: a pilot study.
    García JJ; Carvajal-Gil J; Guerrero-Bonmatty R
    Innate Immun; 2016 Jan; 22(1):3-8. PubMed ID: 26341115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered monocytic phenotypes are linked with systemic inflammation and may be linked to mortality in dialysis patients.
    Brandt S; Ewert L; Scurt FG; Reichardt C; Lindquist JA; Gorny X; Isermann B; Mertens PR
    Sci Rep; 2019 Dec; 9(1):19103. PubMed ID: 31836803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.